Related Experiment Video
Updated: May 6, 2026
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Targeting metabolic scavenging in pancreatic cancer
Costas A Lyssiotis1, Lewis C Cantley
1Authors' Affiliation: Department of Medicine, Weill Cornell Medical College, New York City, New York.
Abstract:
Pancreatic tumor metabolism is rewired to facilitate survival and growth in a nutrient-depleted environment. This leads to a unique dependence on metabolic recycling and scavenging pathways, including NAD salvage. Targeting this pathway in pancreatic cancer disrupts metabolic homeostasis and impairs tumor growth.
Insights
Pancreatic tumors rewire metabolism for survival, relying on pathways like nicotinamide adenine dinucleotide (NAD) salvage. Targeting this NAD salvage pathway disrupts cancer cell metabolism and hinders tumor growth.
Area of Science:
- Oncology
- Cancer Metabolism
- Biochemistry
Background:
- Pancreatic tumors exhibit metabolic rewiring to survive nutrient-poor environments.
- This adaptation creates dependencies on specific metabolic pathways for tumor progression.
Purpose of the Study:
- To investigate the role of metabolic recycling and scavenging pathways in pancreatic cancer.
- To determine the therapeutic potential of targeting the NAD salvage pathway in pancreatic tumors.
Main Methods:
- Analysis of metabolic pathways in pancreatic tumor models.
- Investigating the impact of targeting NAD salvage on tumor cell metabolism and growth.
Main Results:
- Pancreatic cancer cells show a significant dependence on NAD salvage pathways.
- Inhibition of NAD salvage disrupts metabolic homeostasis within tumor cells.
- Targeting this pathway effectively impairs pancreatic tumor growth.
Conclusions:
- The NAD salvage pathway is a critical metabolic vulnerability in pancreatic cancer.
- Targeting NAD salvage represents a promising therapeutic strategy for pancreatic cancer treatment.
